Searched over 200M research papers
10 papers analyzed
These studies suggest losartan can improve heart rate variability and reduce heart rate in various conditions, including heart failure and hypertension.
20 papers analyzed
Losartan is a widely used angiotensin II receptor antagonist, primarily prescribed for managing hypertension and heart failure. By blocking the angiotensin II receptor, losartan helps in reducing blood pressure and improving cardiovascular outcomes. This article synthesizes the current research on the effects of losartan on heart rate, particularly in patients with heart failure and hypertension.
Research has shown that losartan has significant hemodynamic benefits in patients with heart failure. In a multicenter study, patients treated with losartan exhibited a reduction in systemic vascular resistance and blood pressure, along with a decrease in heart rate across all active treatment groups. These effects were observed both after the first dose and after 12 weeks of continuous treatment, indicating both short-term and long-term benefits.
Losartan has also been found to improve heart rate variability (HRV) and heart rate turbulence in patients with ischemic cardiomyopathy. A study involving patients already on beta-blockers and ACE inhibitors demonstrated that adding losartan significantly improved various HRV parameters and heart rate turbulence indices over a 12-week period. This suggests that losartan can enhance autonomic regulation of heart rate in heart failure patients.
In hypertensive patients, losartan has been shown to maintain a balanced autonomic modulation during vasodilation. A study involving hypertensive patients undergoing a tilt test and trinitroglycerine vasodilation found that losartan treatment prevented the sympathetic prevalence typically observed during these procedures, thereby maintaining a significant vagal component. This indicates that losartan can help in stabilizing heart rate variability in hypertensive patients.
Animal studies have provided additional insights into losartan's effects on heart rate. In nonhuman primates, losartan administration did not significantly alter heart rate, although it did induce hypotension and hyper-reninemia. Similarly, in salt-deplete dogs, losartan caused a rise in heart rate at higher doses, alongside a reduction in blood pressure. These findings suggest that while losartan primarily affects blood pressure, its impact on heart rate may vary depending on the physiological context.
Losartan has demonstrated significant benefits in managing heart rate and improving heart rate variability in both heart failure and hypertensive patients. Its ability to reduce systemic vascular resistance and maintain autonomic balance makes it a valuable therapeutic option. Further research is needed to fully understand the long-term implications of losartan on heart rate and its potential benefits in broader patient populations.
Most relevant research papers on this topic